BioCentury
ARTICLE | Company News

Debiopharm receives FDA approval

July 5, 2001 7:00 AM UTC

The FDA granted marketing authorization for Debiopharm's Trelstar LA triptorelin pamoate LHRH agonist to treat advanced prostate cancer. Trelstar LA is a controlled release, intramuscular injection fo...